Bob Kronemyer (Contributor)
Blood testing was far more accurate, Lund University researchers reported Sunday at the Alzheimer’s Association International Conference in Philadelphia. The primary care doctors’ initial diagnosis was 61% accurate and the specialists’ 73% — but the blood test was 91% accurate, according to the ...
Researchers at the University of Melbourne have developed a promising blood test for earlyAlzheimer’sdisease detection by measuring potassium isotopes in blood serum, offering a potential breakthrough in managing and slowing the disease’s progression. New research has identified a promising new method ...
Sticky plaques start forming in the brain 15 years before Alzheimer’s disease develops. A simple blood test may identify those at risk years in advance
A new biosensor using neatly alignedcarbon nanotubesmay bring scientists one step closer to a blood test for the early detection ofAlzheimer’s disease. The nanotubes were able to measure microscopic concentrations of Alzheimer’s main protein biomarkers in blood plasma, and r...
Blood test could help diagnose Alzheimer’s disease A study from Sweden shows early but promising results for a straightforward blood test for Alzheimer's disease that could be easier for doctors to administer, but which is not yet approved by the FDA....
A large team of researchers affiliated with a host of institutions across South Korea has developed a possible blood test to detect the early stages of Alzheimer's disease in patients who have yet to exhibit symptoms. In their paper published in the jour
“We see this as a major step towards global clinical implementation of an Alzheimer’s blood test,” Hansson says. "The next steps include establishing clear guidelines for how an Alzheimer’s blood test can be used in clinical practice, preferably by implementing these tests first in specialist...
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Prof. Ip and her team developed a blood test for early detection and screening of Alzheimer’s disease from Chinese patient data, with an accuracy level of over 96%. Credit: HKUST ...
Oakley said there were “potentially groundbreaking new drugs” that could slow the progression of early-stage Alzheimer’s. But patients would need “an early, accurate diagnosis” to be eligible for them if the products were approved by global regulators, he added. ...